Is Resgen overvalued or undervalued?

As of 19 September 2025, the valuation grade for Resgen has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its key financial ratios, including a PE Ratio of 24.65, an EV to EBIT of 16.91, and an EV to EBITDA of 12.98. These figures suggest that Resgen's stock price does not align favorably with its earnings and cash flow metrics.
In comparison to its peers, Resgen's PE Ratio is significantly lower than that of Larsen & Toubro, which stands at 32.64, while also being higher than CG Power & Industries, which is deemed very expensive at a PE of 122.68. This peer comparison reinforces the notion that Resgen is overvalued, especially given the broader context of its recent performance, where it has underperformed the Sensex over the past year with a return of -43.65% compared to -0.67% for the index.